• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人羊水促凝活性的研究。II. 因子VII的作用。

Studies on the procoagulant activity of human amniotic fluid. II. The role of factor VII.

作者信息

Pusey M L, Mende T J

出版信息

Thromb Res. 1985 Sep 1;39(5):571-85. doi: 10.1016/0049-3848(85)90237-3.

DOI:10.1016/0049-3848(85)90237-3
PMID:3936221
Abstract

Partially purified Amniotic Fluid Factor (AFF) is found to directly activate human factor X, with a Km for factor X of 0.37 +/- 0.06 M. Added phospholipid has only a slight effect on the activation at low concentrations, and inhibits the reaction at higher concentrations. Both DIPF and PMSF inhibit AFF factor X activation. Although added phospholipid is not required for AFF-activity, phospholipase C rapidly destroys it, indicating the presence of intrinsic phospholipid. Phospholipase C treated AFF releases factor VII activity, which leads to the conclusion that AFF is in fact a thromboplastin: factor VII complex. Both AFF and a human brain thromboplastin factor VII complex prepared in vitro were inhibited by Zn++ ion, while human brain thromboplastin alone is not. AFF is markedly larger than the human brain thromboplastin-factor VII complex as judged by gel filtration.

摘要

部分纯化的羊水因子(AFF)被发现可直接激活人因子X,其对因子X的米氏常数(Km)为0.37±0.06M。添加的磷脂在低浓度时对激活仅有轻微影响,而在高浓度时则抑制该反应。二异丙基氟磷酸(DIPF)和苯甲基磺酰氟(PMSF)均抑制AFF对因子X的激活。尽管AFF的活性不需要添加磷脂,但磷脂酶C能迅速破坏它,这表明存在内在磷脂。经磷脂酶C处理的AFF释放出因子VII活性,由此得出结论,AFF实际上是一种凝血活酶:因子VII复合物。AFF和体外制备的人脑凝血活酶因子VII复合物均被Zn++离子抑制,而单独的人脑凝血活酶则不受抑制。通过凝胶过滤判断,AFF明显大于人脑凝血活酶 - 因子VII复合物。

相似文献

1
Studies on the procoagulant activity of human amniotic fluid. II. The role of factor VII.人羊水促凝活性的研究。II. 因子VII的作用。
Thromb Res. 1985 Sep 1;39(5):571-85. doi: 10.1016/0049-3848(85)90237-3.
2
Studies on the procoagulant activity of human amniotic fluid. I. Stability and coagulation factor requirements.人羊水促凝活性的研究。I. 稳定性及凝血因子需求
Thromb Res. 1985 Aug 1;39(3):355-68. doi: 10.1016/0049-3848(85)90231-2.
3
The coagulation factor VII in pregnancy.孕期的凝血因子VII
Br J Haematol. 1984 Feb;56(2):233-41. doi: 10.1111/j.1365-2141.1984.tb03951.x.
4
A study of the procoagulant properties of amniotic fluid and their correlation with the lecithin/sphingomyelin ratio.羊水促凝特性及其与卵磷脂/鞘磷脂比值相关性的研究。
Br J Obstet Gynaecol. 1981 Feb;88(2):133-7. doi: 10.1111/j.1471-0528.1981.tb00956.x.
5
The role of factor VII in the intrinsic pathway: a brief review.
Haemostasis. 1983;13(3):156-60. doi: 10.1159/000214721.
6
Regulation of the initiation of coagulation by factor VII.
Haemostasis. 1983;13(3):150-5. doi: 10.1159/000214720.
7
Procoagulant properties of amniotic fluid.羊水的促凝血特性。
Am J Obstet Gynecol. 1972 Aug 1;113(7):911-9. doi: 10.1016/0002-9378(72)90656-4.
8
Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.使用膜联蛋白-V来证明磷脂酰丝氨酸暴露在内皮细胞维持止血平衡中的作用。
Biochem J. 1992 Feb 15;282 ( Pt 1)(Pt 1):7-13. doi: 10.1042/bj2820007.
9
The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.钙离子、磷脂和组织因子载脂蛋白对活化的因子 VII 激活人凝血因子 X 的作用。
Biochem J. 1990 Jan 15;265(2):327-36. doi: 10.1042/bj2650327.
10
Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis.狨猴博来霉素诱导的肺损伤中支气管肺泡灌洗促凝活性。其特征及与纤维蛋白沉积和纤维化的关系。
Am Rev Respir Dis. 1987 Jul;136(1):124-33. doi: 10.1164/ajrccm/136.1.124.

引用本文的文献

1
Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII.羊水、乳汁、唾液和尿液中的细胞外囊泡暴露了组织因子和激活的因子 VII 的复合物。
J Thromb Haemost. 2022 Oct;20(10):2306-2312. doi: 10.1111/jth.15801. Epub 2022 Jul 29.
2
Development and validation of an assay for urinary tissue factor activity.尿组织因子活性检测方法的开发与验证
J Clin Pathol. 1999 Mar;52(3):219-24. doi: 10.1136/jcp.52.3.219.
3
Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.
促凝血活性可能是实验性前列腺癌恶性表型的一个标志物。
Br J Cancer. 1994 Feb;69(2):286-90. doi: 10.1038/bjc.1994.53.